Literature DB >> 8008710

Accumulation kinetics of propranolol in the rat: comparison of Michaelis-Menten-mediated clearance and clearance changes consistent with the "altered enzyme hypothesis".

C Weber1, K Stoeckel, D Lalka.   

Abstract

(+)-Propranolol was infused at two rates into the pyloric vein (a portal vein tributary) of 15 male Sprague Dawley rats until apparent steady-state conditions were established (i.e., 8 hr at each rate). One group (n = 7) received the high dose (40 micrograms/min/kg) first, and in the other group (n = 8) the low dose (20 micrograms/kg/min) was used to initiate treatment. Free and total serum concentrations of propranolol were measured. When the low dose was given first, the apparent steady-state concentrations achieved during low- and high-rate infusion steps were 166 +/- 37 and 774 +/- 235 ng/mL, respectively. These data are consistent with a simple Michaelis-Menten kinetic model and the key parameters of such a model (Vmax and Km) were estimated. However, a crucial test of such a model (and one which should give insight regarding the relevance of an "altered enzyme hypothesis") is to reverse the order of infusion steps since, in a system controlled by Michaelis-Menten kinetics, the same steady-state concentrations should be achieved regardless of the order in which infusion steps are given. When the sequence of infusion rates was reversed, steady-state concentrations were 492 +/- 142 and 298 +/- 79 ng/mL for the high and low infusion rates, respectively. Clearly, a history of high-dose exposure reduces the intrinsic clearance of total drug (CLss) during a subsequent low-dose exposure (i.e., the apparent steady-state levels during the low-dose pyloric vein infusions were significantly different; P < 0.001). When these data were corrected for plasma protein binding, the same trends emerged.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008710     DOI: 10.1023/a:1018921306200

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Drug absorption and metabolism studies by use of portal vein infusion in the rat. II. Influence of dose and infusion rate on the bioavailability of propranolol.

Authors:  T Suzuki; S Isozaki; T Ishida; Y Saito; F Nakagawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1974-07       Impact factor: 1.645

2.  The disposition of propranolol. IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver.

Authors:  G H Evans; G R Wilkinson; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

3.  Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

Authors:  G H Evans; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

4.  Effect of surgery on serum alpha 1-acid glycoprotein concentration and serum protein binding of DL-propranolol in phenobarbital-treated and untreated rats.

Authors:  T H Lin; Y Sugiyama; Y Sawada; Y Suzuki; T Iga; M Hanano
Journal:  Drug Metab Dispos       Date:  1987 Jan-Feb       Impact factor: 3.922

Review 5.  Suicidal destruction of cytochrome P-450 during oxidative drug metabolism.

Authors:  P R Oritz de Montellano; M A Correia
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

6.  A nonlinear physiologic pharmacokinetic model: I. Steady-state.

Authors:  J G Wagner; G J Szpunar; J J Ferry
Journal:  J Pharmacokinet Biopharm       Date:  1985-02

7.  Dose-dependent elimination of propranolol and its major metabolites in humans.

Authors:  B M Silber; N H Holford; S Riegelman
Journal:  J Pharm Sci       Date:  1983-07       Impact factor: 3.534

8.  Selective mechanism-based inactivation of the major phenobarbital-inducible P-450 cytochrome from rabbit liver by phencyclidine and its oxidation product, the iminium compound.

Authors:  Y Osawa; M J Coon
Journal:  Drug Metab Dispos       Date:  1989 Jan-Feb       Impact factor: 3.922

9.  Effects of chlorpromazine on the disposition and beta-adrenergic blocking activity of propranolol in the dog.

Authors:  S A Bai; F P Abramson
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

10.  Measurement of hepatic blood flow after severe hemorrhage: lack of restoration despite adequate resuscitation.

Authors:  P Wang; Z F Ba; J Burkhardt; I H Chaudry
Journal:  Am J Physiol       Date:  1992-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.